Anavex 2-73 / Blarcamesine
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 04/10/2020
Pipeline Type
New Drugs in Development
Phase Of Development
Phase 1
Sponsors and Collaborators
Anavex Life Science Corp/ International Rett Syndrome Foundation
Mechanism of Action
Sigma-1
Mechanism Description
modulates sigma-1 receptor
Populations Tested In
Infantile Spasms Phase 1/ (Note: Also in Rett Syndrome for Phase 2)
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
International Rett Syndrome Foundation
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
AEDD XV - May 2019
Location of Clinical Trials
N/A
Clinical Trial link